Intravitreal Bevacizumab for Nonproliferative Diabetic Retinopathy (Q113891543)
Jump to navigation
Jump to search
clinical trial
Language | Label | Description | Also known as |
---|---|---|---|
English | Intravitreal Bevacizumab for Nonproliferative Diabetic Retinopathy |
clinical trial |
Statements
Efficacy and Safety of Intravitreal Bevacizumab for the Improvement of Severe Non-proliferative Diabetic Retinopathy Without DME: a Randomized Clinical Trial (English)
0 references
1 September 2020
0 references
1 January 2021
0 references
100
0 references
18 year
0 references
80 year
0 references